Chemomab Therapeutics Ltd. (CMMB) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Total Current Assets | 13.42M | 11.93M | 10.61M | 11.98M | 16.04M | 19.89M | 13.46M | 16.84M | 20.9M | 22.37M | 27.7M | 33.78M | 41.74M | 48.73M | 54.83M | 59.34M | 62.69M | 65.84M | 68.83M | 59.52M |
| Cash & Short-Term Investments | 10.37M | 10.06M | 9.37M | 10.56M | 14.27M | 19.38M | 12.73M | 15.95M | 19.86M | 21.44M | 26.59M | 32.71M | 39.89M | 46.47M | 51.72M | 57.41M | 61.16M | 64.27M | 66.92M | 58.2M |
| Cash Only | 7.56M | 6.97M | 5.45M | 8.34M | 6.07M | 6.6M | 5.04M | 4.74M | 9.37M | 9.23M | 10.38M | 20.77M | 13.52M | 10.74M | 9.88M | 13.83M | 14.69M | 37.74M | 45.4M | 58.18M |
| Short-Term Investments | 2.8M | 3.08M | 3.92M | 2.23M | 8.2M | 12.78M | 7.69M | 11.21M | 10.49M | 12.22M | 16.21M | 11.94M | 26.37M | 35.73M | 41.84M | 43.58M | 46.48M | 26.52M | 21.52M | 23K |
| Accounts Receivable | 3.06M | 1.72M | 1.1M | 1.27M | 263K | 439K | 654K | 885K | 289K | 921.99K | 1.04M | 995K | 459K | 2.26M | 3.11M | 1.93M | 179K | 1.57M | 1.92M | 320K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -993 | 72.88K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | 174.62 | 419.3 | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 149K | 148K | 140K | 76K | 75K | 74.04K | 6 | 7 | 0 | 1.12K | 77K | 77K | 0 | 0 | 0 | 0 | 0 | 0 | 1M |
| Total Non-Current Assets | 386.99K | 442K | 515K | 842K | 924K | 1M | 1.09M | 1.17M | 1.25M | 1.05M | 1.14M | 1.24M | 1.33M | 1.49M | 1.55M | 1.62M | 1.67M | 1.6M | 1.68M | 600K |
| Property, Plant & Equipment | 176K | 188K | 217K | 501K | 539K | 577K | 617K | 656K | 695K | 448.99K | 498K | 545K | 594K | 641K | 650K | 667K | 702K | 593K | 635K | 545K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 6.62K | 0 | 0 | 0 | 8.02K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77K | 77K | 85K | 55K | 53K | 53K | 4K |
| Other Non-Current Assets | 211K | 254K | 298K | 341K | 378.38K | 428K | 472K | 516K | 550.98K | 602.99K | 646K | 690K | 733K | 776K | 821K | 864K | 908K | 952K | 995K | 51K |
| Total Assets | 13.81M | 12.37M | 11.13M | 12.82M | 16.96M | 20.9M | 14.54M | 18.01M | 22.15M | 23.42M | 28.85M | 35.01M | 43.06M | 50.22M | 56.38M | 60.96M | 64.35M | 67.44M | 70.52M | 60.12M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -18.58% | -40.81% | -23.48% | -28.82% | -23.42% | -10.76% | -49.59% | -48.56% | -48.56% | -53.37% | -48.83% | -42.56% | -33.08% | -25.54% | -20.05% | 1.39% | 415.81% | 777.1% | 604.05% | 295.99% |
| Total Current Liabilities | 1.48M | 1.14M | 1.43M | 2.25M | 3.22M | 4.35M | 4.31M | 4.4M | 4.84M | 5.37M | 6.83M | 7M | 6.75M | 5.48M | 4.39M | 3.52M | 2.65M | 1.63M | 2.16M | 4.63M |
| Accounts Payable | 484.99K | 194K | 378K | 490K | 666K | 386K | 1.11M | 527K | 516K | 730.99K | 2.35M | 2.22M | 1.69M | 1.25M | 1.43M | 1.49M | 1.34M | 481K | 472K | 2.08M |
| Days Payables Outstanding | - | - | - | - | - | - | 2.77K | - | 3.55K | 7.48K | 13.13K | 19.42 | 9.67K | 14.82 | 21.24 | 9.75K | 7.56K | 4.85K | 16.55K | 14.13K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 115K | 112K | 109K | 110K | 76K | 0 | 0 | 115K | 0 | 0 | 132K | 0 | 0 | 61K | 72K | 69K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 337K | 479K | 386K | 279K | 759K | 615K | -108.99K | -109.97K | 3.35M | 3.01M | 1.87M | 3.05M | 1.56M | 1.53M | 1.58M | 666K | 653K | 576K | 905K | 1.89M |
| Current Ratio | 9.08x | 10.49x | 7.42x | 5.33x | 4.98x | 4.57x | 3.12x | 3.83x | 4.32x | 4.16x | 4.06x | 4.83x | 6.18x | 8.90x | 12.48x | 16.87x | 23.66x | 40.39x | 31.88x | 12.85x |
| Quick Ratio | 9.08x | 10.49x | 7.42x | 5.33x | 4.98x | 4.57x | 3.12x | 3.83x | 4.32x | 4.17x | 4.05x | 4.83x | 6.18x | 8.90x | 12.48x | 16.87x | 23.66x | 40.39x | 31.88x | 12.85x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 179K | 209K | 230K | 251K | 280K | 316K | 5K | 33K | 62K | 91K | 118K | 148K | 203K | 237K | 298K | 320K | 328K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 179K | 209K | 230K | 251K | 280K | 316K | 5K | 33K | 62K | 91K | 118K | 148K | 203K | 237K | 298K | 320K | 328K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.48M | 1.14M | 1.43M | 2.43M | 3.43M | 4.58M | 4.56M | 4.68M | 5.15M | 5.37M | 6.86M | 7.06M | 6.84M | 5.59M | 4.54M | 3.72M | 2.89M | 1.93M | 2.48M | 4.96M |
| Total Debt | 0 | 0 | 0 | 292K | 324K | 342K | 360K | 390K | 392K | 110K | 141K | 177K | 214K | 244K | 280K | 319K | 343K | 359K | 392K | 397K |
| Net Debt | -7.56M | -6.97M | -5.45M | -8.05M | -5.75M | -6.26M | -4.68M | -4.35M | -8.98M | -9.12M | -10.24M | -20.59M | -13.3M | -10.5M | -9.6M | -13.51M | -14.34M | -37.38M | -45M | -57.78M |
| Debt / Equity | - | - | - | 0.03x | 0.02x | 0.02x | 0.04x | 0.03x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | -2028.06x | - | - | - | - | - | - | -13.18x | - | -416.76x | -37.37x | -161.35x | -343.36x |
| Total Equity | 12.33M | 11.23M | 9.7M | 10.39M | 13.54M | 16.32M | 9.99M | 13.33M | 17M | 18.04M | 21.99M | 27.95M | 36.22M | 44.62M | 51.84M | 57.24M | 61.47M | 65.51M | 68.04M | 55.16M |
| Equity Growth % | -8.89% | -31.17% | -2.86% | -22.04% | -20.36% | -9.56% | -54.59% | -52.31% | -53.08% | -59.57% | -57.58% | -51.16% | -41.07% | -31.88% | -23.81% | 3.76% | 469.02% | 1124.29% | 734.12% | 345.84% |
| Book Value per Share | 1.58 | 1.82 | 1.67 | 1.82 | 2.87 | 3.72 | 2.79 | 3.75 | 5.22 | 6.10 | 7.94 | 10.12 | 12.46 | 15.60 | 18.17 | 20.07 | 21.57 | 22.99 | 25.17 | 28.15 |
| Total Shareholders' Equity | 12.33M | 11.23M | 9.7M | 10.39M | 13.54M | 16.32M | 9.99M | 13.33M | 17M | 18.04M | 21.99M | 27.95M | 36.22M | 44.62M | 51.84M | 57.24M | 61.47M | 65.51M | 68.04M | 55.16M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -111.62M | -109.75M | -108M | -105.95M | -102.62M | -99.66M | -96.18M | -92.55M | -88.68M | -84.62M | -80.54M | -72.57M | -63.82M | -55.55M | -47.47M | -41.28M | -36.17M | -31.14M | -28.17M | -25.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.22M | -1.22M | -1.22M | -1.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |